A detailed history of Northwest Bancshares, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Northwest Bancshares, Inc. holds 1,476 shares of AMGN stock, worth $475,581. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,476
Previous 1,491 1.01%
Holding current value
$475,581
Previous $423,000 8.98%
% of portfolio
0.08%
Previous 0.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$262.75 - $319.31 $3,941 - $4,789
-15 Reduced 1.01%
1,476 $461,000
Q1 2024

Apr 26, 2024

BUY
$268.87 - $324.56 $25,273 - $30,508
94 Added 6.73%
1,491 $423,000
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $176,688 - $199,325
-691 Reduced 33.09%
1,397 $402,000
Q3 2023

Oct 27, 2023

SELL
$218.65 - $271.46 $8,527 - $10,586
-39 Reduced 1.83%
2,088 $561,000
Q2 2023

Jul 24, 2023

SELL
$214.27 - $253.37 $462,180 - $546,519
-2,157 Reduced 50.35%
2,127 $472,000
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $1.29 Million - $1.57 Million
-5,708 Reduced 57.13%
4,284 $1.04 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $2.85 Million - $3.62 Million
-12,432 Reduced 55.44%
9,992 $2.62 Million
Q3 2022

Nov 15, 2022

SELL
$224.46 - $253.15 $56,339 - $63,540
-251 Reduced 1.11%
22,424 $5.05 Million
Q2 2022

Aug 16, 2022

SELL
$230.71 - $256.74 $123,660 - $137,612
-536 Reduced 2.31%
22,675 $5.52 Million
Q1 2022

Apr 29, 2022

SELL
$219.27 - $242.57 $95,601 - $105,760
-436 Reduced 1.84%
23,211 $5.61 Million
Q4 2021

Feb 09, 2022

BUY
$198.88 - $227.6 $241,639 - $276,534
1,215 Added 5.42%
23,647 $5.32 Million
Q3 2021

Oct 13, 2021

BUY
$212.27 - $248.7 $244,747 - $286,751
1,153 Added 5.42%
22,432 $4.77 Million
Q2 2021

Aug 06, 2021

BUY
$233.58 - $259.14 $194,572 - $215,863
833 Added 4.07%
21,279 $5.19 Million
Q1 2021

Apr 23, 2021

BUY
$221.91 - $258.6 $197,721 - $230,412
891 Added 4.56%
20,446 $5.09 Million
Q4 2020

Feb 05, 2021

BUY
$216.38 - $257.67 $593,963 - $707,304
2,745 Added 16.33%
19,555 $4.5 Million
Q3 2020

Oct 20, 2020

SELL
$234.65 - $260.95 $198,748 - $221,024
-847 Reduced 4.8%
16,810 $4.27 Million
Q2 2020

Aug 07, 2020

BUY
$197.81 - $242.74 $273,175 - $335,223
1,381 Added 8.48%
17,657 $4.16 Million
Q1 2020

May 05, 2020

BUY
$182.24 - $241.7 $21,139 - $28,037
116 Added 0.72%
16,276 $3.3 Million
Q4 2019

Feb 10, 2020

SELL
$189.21 - $243.2 $160,071 - $205,747
-846 Reduced 4.97%
16,160 $3.9 Million
Q3 2019

Oct 09, 2019

BUY
$174.11 - $208.62 $116,305 - $139,358
668 Added 4.09%
17,006 $3.29 Million
Q2 2019

Jul 17, 2019

BUY
$166.7 - $195.41 $160,698 - $188,375
964 Added 6.27%
16,338 $3.01 Million
Q1 2019

Apr 24, 2019

BUY
$180.87 - $203.88 $166,038 - $187,161
918 Added 6.35%
15,374 $2.92 Million
Q4 2018

Feb 08, 2019

BUY
$178.4 - $208.25 $405,324 - $473,144
2,272 Added 18.65%
14,456 $2.81 Million
Q3 2018

Oct 02, 2018

BUY
$185.29 - $208.89 $91,718 - $103,400
495 Added 4.23%
12,184 $2.53 Million
Q2 2018

Aug 09, 2018

BUY
$166.05 - $186.51 $9,630 - $10,817
58 Added 0.5%
11,689 $2.16 Million
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $121,650 - $142,164
718 Added 6.58%
11,631 $1.98 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $1.84 Million - $2.06 Million
10,913
10,913 $1.9 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Northwest Bancshares, Inc. Portfolio

Follow Northwest Bancshares, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Bancshares, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northwest Bancshares, Inc. with notifications on news.